Statistics
Publications
1
Citations
82
H-Index
1
Active since
2023
Affiliations
Sana Biotechnology (United States)(Current)
Karl Manner is an author at Sana Biotechnology (United States) specializing in chimeric antigen receptor t-cell therapy, allogeneic car t-cell therapy, and crispr-cas9 knockout.
Publications per year
2023–2023
1
1